Is AXSM up or down today?
AXSM is up 5.43% today, last at 222.58. This stock moved +5.43% versus the prior close.
AXSM · AXSM
AXSM (AXSM) is trading at 222.58, up 5.43% on the session. AXSM sits at the 74% mark of its 52-week range, carries a 14-day RSI of 61, and trades above its 50-day average. Over the past month it is up 3.16%.
Leading the coverage: “The Bull Case For Axsome Therapeutics (AXSM) Could Change Following AXS-05 Phase 3 Smoking Trial Launch - simplywall.st” (Google News, 4d ago). AXSM is -3.72% since story.
AXSM trades on a trailing P/E of 13.9 and is running 3.85% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
AXSM is up 5.43% today, last at 222.58. This stock moved +5.43% versus the prior close.
Leading the coverage: “The Bull Case For Axsome Therapeutics (AXSM) Could Change Following AXS-05 Phase 3 Smoking Trial Launch - simplywall.st” (Google News, 4d ago). AXSM is -3.72% since story. Dominant story: Axsome rises on Auvelity prescription data (1 source, bullish) RSI is 61 — leaning bullish Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (125 days) · Drag or scroll left for earlier dates
Axsome rises on Auvelity prescription data
Axsome Therapeutics (NASDAQ:AXSM) Trading Up 7% - Should You Buy? - MarketBeat
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - Yahoo Finance
Axsome Therapeutics vs. CRISPR Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Analysts Offer Insights on Healthcare Companies: Zymeworks (ZYME), Axsome Therapeutics (AXSM) and Ocugen (OCGN) - The Globe and Mail